Clinical Trial

S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated April 3, 2025 (before its estimated July 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to investigate clinical effects (liver biochemistries, health-related quality of life, liver stiffness) and underlying mechanisms of hepatoprotection of S-adenosylmethionine in patients with primary sclerosing cholangitis. The study will be performed in a randomized and placebo-controlled fashion.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06026865
Lead Sponsor Medical University of Warsaw
Collaborators: National Science Centre, Poland
Conditions Primary Sclerosing Cholangitis (PSC)
Enrollment 60 participants
Start Date 2023-08-01
Primary Completion 2025-07-31 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-03